POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: A single-institution experience

Annals of Hematology

Volumn 91, Issue 9, 2012, Pages 1419-1425

  Thoennissen, Gabriela B ^a   Thoennissen, Nils H ^a   Fritz, Fleur ^b   Hilbig, Andreas ^a   Kerkhoff, Andrea ^a   Liersch, Ruediger ^a   Krug, Utz ^a   Koschmieder, Steffen ^a,c   Müller Tidow, Carsten ^a   Mesters, Rolf ^a   Kropff, Martin ^a   Berdel, Wolfgang E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Autologous stem cell transplantation; Clinical observation; Melphalan high dose therapy; Plasma cell proliferative disorder; POEMS

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; COLOSTOMY; DEATH; DRUG MEGADOSE; DRUG RESPONSE; ENGRAFTMENT SYNDROME; FEMALE; HEMICOLECTOMY; HUMAN; KIDNEY FAILURE; LARGE CELL LYMPHOMA; MALE; NEUTROPENIA; PLASMAPHERESIS; PLEURA EFFUSION; POEMS SYNDROME; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

ADULT; ANTHRACYCLINES; COMBINED MODALITY THERAPY; DEXAMETHASONE; FEMALE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MYELOABLATIVE AGONISTS; NEUROLOGIC EXAMINATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POEMS SYNDROME; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864927232     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1473-7     Document Type: Article

References (35)

1. Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y (1984) The Crow- Fukase syndrome: a study of 102 cases in Japan. Neurology 34:712-720
2. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes: the POEMS syndrome: report on two cases and a review of the literature. Medicine 59:311-322
3. Driedger H, Pruzanski W (1980) Plasma cell neoplasia with peripheral polyneuropathy: a study of five cases and a review of the literature. Medicine 59:301-310
4. Soubrier M, Dubost JJ, Sauvezie B, French Study Group on POEMS Syndrome (1994) POEMS syndrome: a study of 25 cases and a review of the literature. Am J Med 97:543-553
5. Singh D,Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V (2003) POEMS syndrome: experience with fourteen cases. Leuk Lymphoma 44:1749-1752
6. Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, Piette JC, Rousset H, Deteix P (1999) Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 34:633-638
7. Zhang B, SongX, Liang B, HouQ, Pu S, Ying JR, Gao C (2010) The clinical study of POEMS syndrome in China. Neuro Endocrinol Lett 31:229-237
8. Li J, Zhou DB, Huang Z, Jiao L, Duan MH, ZhangW, Zhao YQ, Shen T (2011) Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 117:6445-6449
9. Kulkarni GB, Mahadevan A, Taly AB, Yasha TC, Seshagiri KS, Nalini A, Satishchandra P, Veerendrakumar M, Shankar SK (2011) Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. J Clin Neurosci 18:356-360
10. Dispenzieri A (2007) POEMS syndrome. Blood Rev 21:285-299
11. Dispenzieri A (2005) POEMS syndrome. Hematoly Am Soc Hematol Educ Prog 2005:360-367
12. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama K (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347:702
13. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon- Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA (2004) Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 104:3400-3407
14. Samuels BL, Bitran JD (1995) High-dose intravenous melphalan: a review. J Clin Oncol 13:1786-1799
15. Rovira M, Carreras E, Blade J, Graus F, Valls J, Fernández- Avilés F, Montserrat E (2001) Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 115:373-375
16. Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP (2002) High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 99:3057-3059
17. Soubrier M, Ruivard M, Dubost JJ, Sauvezie B, Philippe P (2002) Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant 30:61-62
18. Peggs KS, Paneesha S, Kottaridis PD, Chakraverty RK, Tobias G, Reilly M, Mahendra P, Yong K (2002) Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant 30:401-404
19. Ganti AK, Pipinos I, Culcea E, Armitage JO, Tarantolo S (2005) Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol 79:206-210
20. Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaseko C, Cho RK, Hattori T (2006) Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 66:105-107
21. Laurenti L, De Matteis S, Sabatelli M, Conte A, Chiusolo P, Sorà F, Piccirillo N, Za T, Tarnani M, Rossi E, Leone G, Sica S (2008) Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leuk Res 32:1309-1312
22. Dispenzieri A, Lacy MQ, Hayman SR et al (2008) Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 80:397-406
23. Dispenzieri A (2011) POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86:591-601
24. Rajkumar S, Harousseau J, Durie B et al (2011) Consensus recommendations for the uniform reporting of clinical trials: reports of the International Myeloma Workshop Consensus Panel 1. Blood 117:4691-4695
25. World Health Organization (1979) Handbook for reporting results of cancer treatment. World Health Organization, Geneva, pp 15-22
26. Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, Tian Z, Zhou DB (2011) Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117:6445-6449
27. D'Souza A, Hayman SR, Buadi F et al (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and followup of patients with POEMS syndrome. Blood 118:4663-4665
28. Dispenzieri A, Klein CJ, Mauermann ML (2007) Lenalidomide therapy in a patient with POEMS syndrome. Blood 110:1075-1076
29. Jaccard A, Abraham J, Recher C, Dulery R, Guichard I, Haroche J, Asli B, Amoura Z, Brissaud JM, Musset L, Facon T, Leblond V, Moreau P, Fermand JP, Bordessoule D (2009) Lenalidomide therapy in nine patients with POEMS syndrome. ASH Ann Meeting Abstr 114:3872
30. Tang X, Shi X, Sun A, Qiu H, Gu B, Zhou H, Xue S, Liu Y, Ruan C, Wu D (2009) Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 83:609-610
31. Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M (2010) Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 84:175-177
32. Straume O, Bergheim J, Ernst P (2006) Bevacizumab therapy for POEMS syndrome. Blood 107:4972-4973
33. Badros A, Porter N, Zimrin A (2005) Bevacizumab therapy for POEMS syndrome. Blood 106:1135
34. Badros A (2005) Bevacizumab therapy for POEMS syndrome. Blood 106:1135
35. Stankowski-Drengler T, Gertz MA, Katzmann JA, Lacy MQ, Kumar S, Leung N, Hayman SR, Buadi F, Kyle RA, Rajkumar SV, Dispenzieri A (2010) Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. Am J Hematol 85:431-434